Effects of HER Family–targeting Tyrosine Kinase Inhibitors on Antibody-dependent Cell-mediated Cytotoxicity in HER2-expressing Breast Cancer-Reference-Cited by-同舟云学术

Effects of HER Family–targeting Tyrosine Kinase Inhibitors on Antibody-dependent Cell-mediated Cytotoxicity in HER2-expressing Breast Cancer

Published:2020-10-29 Issue:3 Volume:27 Page:807-818
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Collins Denis M.^ORCID,Madden Stephen F.,Gaynor Nicola,AlSultan Dalal,Le Gal Marion,Eustace Alex J.^ORCID,Gately Kathy A.,Hughes Clare,Davies Anthony M.,Mahgoub Thamir,Ballot Jo,Toomey Sinead^ORCID,O'Connor Darran P.^ORCID,Gallagher William M.^ORCID,Holmes Frankie A.^ORCID,Espina Virginia^ORCID,Liotta Lance,Hennessy Bryan T.,O'Byrne Kenneth J.^ORCID,Hasmann Max^ORCID,Bossenmaier Birgit,O'Donovan Norma,Crown John

Funder

Caroline Foundation

Cancer Clinical Research Trust

Irish Research Council Enterprise Partnership Scheme

Health Research Board

Science Foundation Ireland-funded Molecular Therapeutics for Cancer Ireland

Irish Cancer Society Collaborative Cancer Research Centre BREAST-PREDICT

Roche Products Ireland Ltd

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Supramolecular antibody-drug conjugates for combined antibody therapy and photothermal therapy targeting HER2-positive cancers;International Journal of Biological Macromolecules;2024-10

2. Molecular mechanisms of HER2-targeted therapy and strategies to overcome the drug resistance in colorectal cancer;Biomedicine & Pharmacotherapy;2024-10

3. Depicting Biomarkers for HER2-Inhibitor Resistance: Implication for Therapy in HER2-Positive Breast Cancer;Cancers;2024-07-24

4. Tocopherol-human serum albumin nanoparticles enhance lapatinib delivery and overcome doxorubicin resistance in breast cancer;Nanomedicine;2024-07-02

5. Combined transcriptome and proteome analysis reveals MSN and ARFIP2 as biomarkers for trastuzumab resistance of breast cancer;Breast Cancer Research and Treatment;2024-05-15